The invention relates to a
leukemia marker joint inspection
antibody chip and a kit.
Leukemia markers are at least seventeen markers selected from ENA-78, GCP-2, MDC, MIF, MIP-3a, MPIE-1, MSPa, OPN, GDF-15, HB-EGF, HGF, PDGF-AA, VEGF-D, BLC, G-CSF, TNF-RI, uPAR, TNFa, Fas L, IL4, ICAM-1, IL5, KC, TIMP-1, TARC, IL2, IL7, M-CSF, IL10, IL21, IL-12p70, BDNF, PF-4, EGF, TNFRII and LIGHT. The expressionamounts of a plurality of samples and the
leukemia markers can be measured at the same time, the
leukemia occurrence and
disease course are accurately and comprehensively reflected, and the leukemiadiagnosis,
disease course monitoring and prognosis evaluation level is improved.